Charles Schwab Investment Management Inc Anixa Biosciences Inc Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,785 shares of ANIX stock, worth $28,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,785
Previous 12,785
-0.0%
Holding current value
$28,254
Previous $49,000
20.41%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.16MCall Options Held
14.5KPut Options Held
24.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.08 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC604KShares$1.34 Million0.26% of portfolio
-
Ubs Group Ag536KShares$1.19 Million0.0% of portfolio
-
Mission Wealth Management, LP502KShares$1.11 Million0.04% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA341KShares$753,5010.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $67.8M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...